91
Francesco Perrone, president-elect of Aiom, underlines the need to boost independent clinical research promoted by the National Health Service, capable of keeping up to date with the evolution of diagnostic and therapeutic scenarios and in addition to the profit studies conducted by pharmaceutical companies.